Kinnate Biopharma. has filed a patent for MEK kinase inhibitors and pharmaceutical compositions for disease treatment. Claims 1-39 have been canceled. GlobalData’s report on Kinnate Biopharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Kinnate Biopharma, Targeted cancer therapy was a key innovation area identified from patents. Kinnate Biopharma's grant share as of January 2024 was 11%. Grant share is based on the ratio of number of grants to total number of patents.
The patent application (Publication Number: US20230416286A1) discloses a series of compounds and pharmaceutical compositions for potential medical use. The compounds listed in the claims include various phosphane oxides and amines, such as 1-(3-((2-Fluoro-4-iodophenyl)amino)pyridin-4-yl)phospholane 1-oxide and 4-(Dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine. These compounds are intended for use in pharmaceutical compositions, either as standalone active ingredients or in combination with other excipients.
The patent further specifies certain preferred compounds for pharmaceutical use, such as (R)-4-[Ethyl(methyl)phosphoryl]-N-(2-fluoro-4-iodophenyl)pyridin-3-amine and 5-Chloro-4-(dimethylphosphoryl)-N-(2-fluoro-4-iodophenyl)pyridin-3-amine. These compounds are highlighted for their potential therapeutic benefits and are proposed to be formulated into pharmaceutical compositions with suitable excipients. The disclosed compounds and compositions aim to address specific medical needs and could potentially lead to the development of novel drugs for various conditions.
To know more about GlobalData’s detailed insights on Kinnate Biopharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
